Latest Articles

08. 04. 2021

Correction of the List of reimbursed medicinal products valid as of 8.4.2021

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

31. 03. 2021

List of reimbursed medicinal products valid as of 1.4.2021

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

26. 03. 2021

COVID-19 Vaccination in Non-covid Clinical Trials

With regard to frequent questions associated also with the extended guideline of MHRA (The Medicines and Healthcare Products Regulatory Agency), the British drug agency,...

 

16. 03. 2021

REG-95 version 1

Application for renewal of parallel import authorisation

 

16. 03. 2021

REG-87 version 3

Application for parallel import authorisation         

 

15. 03. 2021

Notification of the commencement of distribution activities within the territory of the Czech Republic based upon distribution authorization for medicinal products issued by another EU member state - after Brexit

State Institute for Drug Control hereby informs UK WDL holders providing distribution activities within the territory of the Czech Republic upon distribution authorization...

 

26. 02. 2021

List of reimbursed medicinal products valid as of 1.3.2021

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

29. 01. 2021

List of reimbursed medicinal products valid as of 1.2.2021

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...